Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials

医学 内科学 荟萃分析 重性抑郁障碍 系统回顾 心理学 心理治疗师 精神科 梅德林 认知 政治学 法学
作者
Shuang Bai,Wenliang Guo,Yangyang Feng,Hong Deng,Gaigai Li,Hao Nie,Guangyu Guo,Haihan Yu,Yang Ma,Jiahui Wang,Shiling Chen,Jing Jie,Jingfei Yang,Yingxin Tang,Zhouping Tang
出处
期刊:Journal of Neurology, Neurosurgery, and Psychiatry [BMJ]
卷期号:91 (1): 21-32 被引量:169
标识
DOI:10.1136/jnnp-2019-320912
摘要

To systematically review the efficacy and safety of anti-inflammatory agents for patients with major depressive disorders.We searched the literature to identify potentially relevant randomised controlled trials (RCTs) up to 1 January 2019. The primary outcome was efficacy, measured by mean changes in depression score from baseline to endpoint. Secondary outcomes included response and remission rates and quality of life (QoL). Safety was evaluated by incidence of classified adverse events. Heterogeneity was examined using the I2 and Q statistic. Pooled standard mean differences (SMDs) and risk ratios (RRs) were calculated. Subgroup meta-analyses were conducted based on type of treatment, type of anti-inflammatory agents, sex, sponsor type and quality of studies.Thirty RCTs with 1610 participants were included in the quantitative analysis. The overall analysis pooling from 26 of the RCTs suggested that anti-inflammatory agents reduced depressive symptoms (SMD -0.55, 95% CI -0.75 to -0.35, I2=71%) compared with placebo. Higher response (RR 1.52, 95% CI 1.30 to 1.79, I2=29%) and remission rates (RR 1.79, 95% CI 1.29 to 2.49, I2=41%) were seen in the group receiving anti-inflammatory agents than in those receiving placebo. Subgroup analysis showed a greater reduction in symptom severity in both the monotherapy and adjunctive treatment groups. Subgroup analysis of non-steroidal anti-inflammatory drugs, omega-3 fatty acids, statins and minocyclines, respectively, disclosed significant antidepressant effects for major depressive disorder (MDD). For women-only trials, no difference in changes of depression severity was found between groups. Subanalysis stratified by sponsor type and study quality led to the same outcomes in favour of anti-inflammatory agents in both subgroups. Changes of QoL showed no difference between the groups. Gastrointestinal events were the only significant differences between groups in the treatment periods.Results of this systematic review suggest that anti-inflammatory agents play an antidepressant role in patients with MDD and are reasonably safe.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
baonali发布了新的文献求助10
1秒前
yyyhhh完成签到,获得积分10
3秒前
ZH完成签到 ,获得积分10
7秒前
7秒前
7秒前
ll完成签到,获得积分10
8秒前
纾缓完成签到,获得积分10
10秒前
潘善若发布了新的文献求助10
10秒前
15秒前
Willy完成签到,获得积分10
16秒前
17秒前
大模型应助史念薇采纳,获得10
17秒前
17秒前
科研通AI2S应助xn201120采纳,获得10
17秒前
19秒前
潘善若发布了新的文献求助10
19秒前
万能图书馆应助GooJohn采纳,获得10
20秒前
梨花酒完成签到,获得积分10
20秒前
阿里山完成签到,获得积分10
21秒前
momo发布了新的文献求助10
22秒前
Amai完成签到,获得积分10
24秒前
Panjiao完成签到 ,获得积分10
28秒前
28秒前
29秒前
30秒前
Owen应助xiaohu采纳,获得10
30秒前
潘善若发布了新的文献求助10
33秒前
Fengliguantou发布了新的文献求助10
34秒前
量子星尘发布了新的文献求助10
35秒前
李健的小迷弟应助momo采纳,获得10
36秒前
38秒前
大模型应助xueyu采纳,获得10
41秒前
做一只快乐的猪猪侠完成签到,获得积分20
41秒前
41秒前
酷炫的之柔完成签到,获得积分10
42秒前
xunxunmimi发布了新的文献求助10
44秒前
45秒前
乂贰ZERO叁完成签到 ,获得积分10
45秒前
思源应助酷炫的之柔采纳,获得10
46秒前
xiaohu发布了新的文献求助10
46秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989263
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253814
捐赠科研通 3270066
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882084
科研通“疑难数据库(出版商)”最低求助积分说明 809136